INBS vs. ECOR, RBOT, MODD, COCH, MLSS, PETV, DRIO, POCI, STRR, and NRXS
Should you be buying Intelligent Bio Solutions stock or one of its competitors? The main competitors of Intelligent Bio Solutions include electroCore (ECOR), Vicarious Surgical (RBOT), Modular Medical (MODD), Envoy Medical (COCH), Milestone Scientific (MLSS), PetVivo (PETV), DarioHealth (DRIO), Precision Optics (POCI), Star Equity (STRR), and NeurAxis (NRXS). These companies are all part of the "medical equipment" industry.
Intelligent Bio Solutions vs. Its Competitors
Intelligent Bio Solutions (NASDAQ:INBS) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.
electroCore has a consensus target price of $25.50, suggesting a potential upside of 407.97%. Given electroCore's stronger consensus rating and higher possible upside, analysts clearly believe electroCore is more favorable than Intelligent Bio Solutions.
Intelligent Bio Solutions has a beta of 4.49, indicating that its share price is 349% more volatile than the S&P 500. Comparatively, electroCore has a beta of 0.34, indicating that its share price is 66% less volatile than the S&P 500.
electroCore has a net margin of -47.84% compared to Intelligent Bio Solutions' net margin of -346.22%. electroCore's return on equity of -221.93% beat Intelligent Bio Solutions' return on equity.
33.0% of Intelligent Bio Solutions shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 1.3% of Intelligent Bio Solutions shares are owned by insiders. Comparatively, 13.8% of electroCore shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Intelligent Bio Solutions has higher earnings, but lower revenue than electroCore. electroCore is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.
In the previous week, Intelligent Bio Solutions had 1 more articles in the media than electroCore. MarketBeat recorded 1 mentions for Intelligent Bio Solutions and 0 mentions for electroCore. Intelligent Bio Solutions' average media sentiment score of 1.17 beat electroCore's score of 0.95 indicating that Intelligent Bio Solutions is being referred to more favorably in the media.
Summary
electroCore beats Intelligent Bio Solutions on 9 of the 16 factors compared between the two stocks.
Get Intelligent Bio Solutions News Delivered to You Automatically
Sign up to receive the latest news and ratings for INBS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding INBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Intelligent Bio Solutions Competitors List
Related Companies and Tools
This page (NASDAQ:INBS) was last updated on 10/16/2025 by MarketBeat.com Staff
